Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study

NCT01760499 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: PV-10
PROCEDURE: Surgery

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]